Neuca S.A. (NEU) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.133x

Based on the latest financial reports, Neuca S.A. (NEU) has a cash flow conversion efficiency ratio of 0.133x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł168.95 Million ≈ $46.50 Million USD) by net assets (zł1.27 Billion ≈ $349.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NEU defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Neuca S.A. - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Neuca S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Neuca S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Neuca S.A. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Der International Home Furnishing Co Ltd
SHE:002631
-0.007x
Eckert & Ziegler Strahlen- und Medizintechnik AG
F:EUZ
0.074x
V2 Retail Limited
NSE:V2RETAIL
0.122x
Auto Partner SA
WAR:APR
-0.001x
Guangzhou Dongfang Hotel Co Ltd
SHE:000524
0.017x
Sri Trang Agro-Industry Public Company Limited
BK:STA
-0.079x
Xiangxue Pharmaceutical
SHE:300147
-0.899x
Covenant Logistics Group, Inc.
NYSE:CVLG
0.071x

Annual Cash Flow Conversion Efficiency for Neuca S.A. (2005–2025)

The table below shows the annual cash flow conversion efficiency of Neuca S.A. from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see Neuca S.A. market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 zł1.27 Billion
≈ $349.35 Million
zł548.86 Million
≈ $151.06 Million
0.432x +865.41%
2024-12-31 zł1.41 Billion
≈ $388.53 Million
zł63.23 Million
≈ $17.40 Million
0.045x -83.57%
2023-12-31 zł1.06 Billion
≈ $290.96 Million
zł288.27 Million
≈ $79.34 Million
0.273x -24.47%
2022-12-31 zł930.54 Million
≈ $256.10 Million
zł335.94 Million
≈ $92.45 Million
0.361x +6.41%
2021-12-31 zł884.81 Million
≈ $243.51 Million
zł300.20 Million
≈ $82.62 Million
0.339x -18.82%
2020-12-31 zł776.80 Million
≈ $213.79 Million
zł324.67 Million
≈ $89.35 Million
0.418x +33.42%
2019-12-31 zł645.62 Million
≈ $177.68 Million
zł202.25 Million
≈ $55.66 Million
0.313x +68.25%
2018-12-31 zł654.89 Million
≈ $180.23 Million
zł121.94 Million
≈ $33.56 Million
0.186x -0.34%
2017-12-31 zł651.72 Million
≈ $179.36 Million
zł121.76 Million
≈ $33.51 Million
0.187x -37.29%
2016-12-31 zł587.58 Million
≈ $161.71 Million
zł175.05 Million
≈ $48.18 Million
0.298x -12.78%
2015-12-31 zł528.19 Million
≈ $145.37 Million
zł180.40 Million
≈ $49.65 Million
0.342x -21.18%
2014-12-31 zł467.42 Million
≈ $128.64 Million
zł202.56 Million
≈ $55.75 Million
0.433x +542.54%
2013-12-31 zł410.66 Million
≈ $113.02 Million
zł27.70 Million
≈ $7.62 Million
0.067x -81.52%
2012-12-31 zł342.21 Million
≈ $94.18 Million
zł124.92 Million
≈ $34.38 Million
0.365x -36.95%
2011-12-31 zł286.86 Million
≈ $78.95 Million
zł166.08 Million
≈ $45.71 Million
0.579x +898.50%
2010-12-31 zł243.37 Million
≈ $66.98 Million
zł14.11 Million
≈ $3.88 Million
0.058x -73.53%
2009-12-31 zł223.67 Million
≈ $61.56 Million
zł48.99 Million
≈ $13.48 Million
0.219x +7.80%
2008-12-31 zł175.26 Million
≈ $48.23 Million
zł35.61 Million
≈ $9.80 Million
0.203x -59.73%
2007-12-31 zł166.62 Million
≈ $45.86 Million
zł84.07 Million
≈ $23.14 Million
0.505x +459.45%
2006-12-31 zł78.46 Million
≈ $21.59 Million
zł-11.01 Million
≈ $-3.03 Million
-0.140x -173.54%
2005-12-31 zł69.16 Million
≈ $19.03 Million
zł13.20 Million
≈ $3.63 Million
0.191x --

About Neuca S.A.

WAR:NEU Poland Medical Distribution
Market Cap
$905.29 Million
zł3.29 Billion PLN
Market Cap Rank
#9533 Global
#45 in Poland
Share Price
zł730.00
Change (1 day)
+1.96%
52-Week Range
zł649.00 - zł850.00
All Time High
zł953.88
About

NEUCA S.A. engages in the wholesale distribution of pharmaceuticals in Poland. It operates through Wholesale Distribution of Medicines, Manufacture of Pharmaceuticals, Medical Operator, Clinical Trials, and Insurance Activities segments. The company offers Rx, OTC drugs, dietary supplements, medical devices, dermocosmetics, hygiene products, personal protective equipment, as well as diagnostic an… Read more